Clinical Trial Update: RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating RAD001 (everolimus) in combination with weekly cisplatin and radiation therapy in locally advanced head and neck cancer; the study wa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• RAD001 (Everolimus) (everolimus)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Head and Neck Cancer | Phase 1 | Status: TERMINATED